ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: PB0972

    “Best of Both Worlds”: Combination Treatment of Desmopressin and FVIII Concentrates in Hemophilia Patients Optimizes Therapy and Reduces Costs

    L.G.R. Romano1, L.M. Schütte1, R.M. van Hest2, K. Meijer3, B.A.P. Laros-van Gorkom4, L. Nieuwenhuizen5, J. Eikenboom6, F.C.J.I. Moenen7, N. Uitslager8, M. Coppens9, M.H. Cnossen10, K. Fijnvandraat11,12, M.H.E. Driessens13, S. Polinder14, F.W.G. Leebeek1, R.A.A. Mahtôt2, M.J.H.A. Kruip1

  • Abstract Number: PB0268

    “Plasma Free” Perioperative Approach during Lung Transplantation Does Not Seem to Impair Secondary Hemostasis Measured by ROTEM

    M. Durila, J. Vajter, J. Berousek, T. Vymazal

  • Abstract Number: PB0269

    “Plasma Free” Perioperative Approach during Lung Transplantation Seems to Decrease FXIII Level which Is Not Clinically Significant

    M. Durila1, M. Solcova2, M. Mikesova3, J. Vajter1, T. Vymazal1

  • Abstract Number: PB2191

    “Gene-gene Interaction” between FXIII-A VAL34LEU and PAI-1 – 675 4G/5G Polymorphisms Can Modify the Risk of Pulmonary Embolism in Young VTE Patients

    A. Chechulova1, S. Kapustin2, V. Soldatenkov2, S. Svitina2, A. Tomchenko3, V. Soroka3

  • Abstract Number: PB2193

    “Gene-gene Interaction” between PAI-1 – 675 4G/5G and TNF-A -308 G/A Polymorphisms Can Modulate the Risk of Pulmonary Embolism in Young Patients with Venous Thromboembolism

    S. Kapustin1, A. Chechulova2, J. Sidorova1, V. Burakov1, V. Soroka2, V. Soldatenkov1, L. Papayan1

  • Abstract Number: PB1473

    «Aspirin-Like» Platelet Defect Induced by Gabapentin: A Case-Report

    T. Baglo1, C. Vayne1,2, J.-B. Valentin1, L. Ardillon1, E.-A. Guery1, Y. Gruel1,2, C. Pouplard1,2

  • Abstract Number: PB1058

    Case report: Inhibitor Improvement with Low Dose Immune Tolerance Induction (ITI) with rFVIIIFc and Emicizumab after Failed First Line Therapy with High Dose ITI

    I. Wieland1, K.-A. Lambeck1, D. Stichel2, A. Orlowski2, C. Königs2

  • Abstract Number: PB2252

    Case report: Renal Vein Thrombosis Associated with Oral Contraceptive Use and Posterior Nutcracker Syndrome

    A. AlHumaidi1, Y. Bin Dous2, M. Almegren3, R. Kazkaz1, S. Naser1

  • Abstract Number: PB2010

    Candida albicans Expresses an Integrin-like Protein that Is Involved in Yeast Adhesion to Endothelial Cells

    D. Nader, G. Curley, S. Kerrigan

  • Abstract Number: PB2195

    De Novo Variants in Antithrombin Deficiency: Incidence and Heterogeneous Mechanisms

    M.E. de la Morena-Barrio1, B. de la Morena-Barrio1, A. Miñano1, R. Teruel-Montoya1, J. Padill1, C. Bravo-Perez1, R. Cifuentes1, J.R. Gonzalez-Porras2, A. Rodriguez-Alen3, M.F. López-Fernández4, F. Velasco5, M.J. Blanco-Bañares6, V. Vicente1, J. Corral1

  • Abstract Number: PB1453

    Ex vivo Observation of Platelet-granulocytes Interactions in Pediatric Patients with Congenital Platelet Defects

    D. Morozova1, A. Martyanov2,3, D. Fedorova3, P. Zharkov3, M. Panteleev2,3, A. Shcherbina3, A. Sveshnikova2,3,4

  • Abstract Number: PB0838

    In vitro and in sillico Analysis of F9 Gene Missense Mutations at Exons 2 and 3 Causative of Severe Hemophilia B

    L. Melendez Aranda1,2, A.R. Jaloma Cruz2, M.M.d.J. Romero Prado3

  • Abstract Number: PB0775

    In vitro Correction of Thrombin Generation by Recombinant Porcine Factor VIII (rpFVIII) in Plasma Containing Anti-Factor VIII Inhibitory Antibodies

    C. Négrier1, J. Oldenburg2, G. Kenet3, N. Tripkovic4, S.L. Meeks5

  • Abstract Number: PB0821

    In vitro Effect of Concizumab on Protein C Activation and Antithrombin Activity

    M. Kjalke, H. Heibroch Petersen, I. Hilden

  • Abstract Number: PB0036

    In vitro Evaluation of the Impact of BCR-ABL Tyrosine Kinase Inhibitors on Atherosclerosis Plaque Rupture

    H. Haguet1, F. Mullier2, C. Graux2, J.-M. Dogné1, J. Douxfils1,3

  • Abstract Number: PB0035

    In vitro Investigation of the Impact of BCR-ABL Tyrosine Kinase Inhibitors on Endothelial Cells

    H. Haguet1, F. Mullier2, C. Graux2, J.-M. Dogné3, J. Douxfils1,4

  • Abstract Number: PB0706

    In vitro Studies of the Blood Compatibility of Water-Soluble Pristine C60 Fullerenes

    T. Halenova1, N. Raksha1, O. Savchuk1, Y. Prylutskyy1, U. Ritter2

  • Abstract Number: PB1647

    Streptococcus pneumoniae Toxin Pneumolysin Renders Platelets Non-Functional

    K. Jahn1, S. Handtke2, R. Palankar2, J. Wesche2, T.P. Kohler1, M. Rohde3, A. Greinacher2, S. Hammerschmidt1

  • Abstract Number: PB1041

    3D Gait Analysis, Hemophilia Joint Health Score, Leg Muscle Laterality, and Biomarkers of Joint Damage: A Cross-sectional Comparative Assessment of Hemophilic Arthropathy

    P. Putz1, S. Durstberger2, C. Kaufmann2, M. Klinger2, K. Widhalm2, J. Rejtö3, C. Male4, I. Pabinger3

  • Abstract Number: PB2423

    90-Day Follow up in Patients with Suspected Deep Vein Thromboses (DVT) who Have Had a DVT Excluded: Should this Be Routine Clinical Practice?

    A. Hughes, M. Good, K. Good, B. Piper, K. Jennings, K. North, D. Kawira, B. Varghese, G. Harwood

  • 1
  • 2
  • 3
  • …
  • 120
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley